-
Latrepirdine (INN, also
known as
dimebolin and sold as
Dimebon) is an
antihistamine drug
which has been used
clinically in
Russia since 1983. Research...
- when
attempting to
ameliorate disease severity. An
example is the drug
Dimebon by Medivation, Inc. In 2009 this drug was in
phase III
clinical trials...
-
coenzyme Q10, riluzole, creatine, minocycline, ethyl-EPA,
phenylbutyrate and
dimebon. AB-1001
Dayalu P,
Albin RL (February 2015). "Huntington disease: pathogenesis...
- PMID 16537199. S2CID 39505659. Wu J, Li Q,
Bezprozvanny I (2008). "Evaluation of
Dimebon in
cellular model of Huntington's disease".
Molecular Neurodegeneration...
- PMID 25108314. Wu J, Li Q,
Bezprozvanny I (October 2008). "Evaluation of
Dimebon in
cellular model of Huntington's disease".
Molecular Neurodegeneration...
- P7C3 (pool 7,
compound 3) is a drug
related to
latrepirdine (
dimebon)
which has
neuroprotective and
proneurogenic effects and may be
potentially useful...
-
Medivation made
false and
misleading statements regarding the
effectiveness of
Dimebon as a
treatment for Alzheimer's disease,
before being revealed that it did...
-
Cyproheptadine Desipramine Desloratadine Dicycloverine Dicyclomine Dilazep Dimebon Doxepin Drofenine Emetine Fendiline Flunarizine Fluoxetine Flupentixol...
- Paul S; Bachurin,
Sergey O; Seely, Lynn; Hung,
David (2008). "Effect of
dimebon on cognition,
activities of
daily living, behaviour, and
global function...
